US Compounding Pharmacies Market is expected to reach US$ 5,069.56 million by 2027

Oral Medication Segment to Lead Market Growth During Forecast Period

According to The Insight Partners market research study of “US compounding pharmaies Market Forecast to 2027 − COVID-19 Impact and Analysis − by Product and Therapeutic Area,” the market is projected to reach US$ 5,069.56 million by 2027 from US$ 3,079.64 million in 2019. The market is estimated to grow at a CAGR of 6.5% from 2020 to 2027. The report highlights trends prevailing in the US compounding pharmacy market and the factors driving market along with those that act as hindrances.

Based on product, the US compounding pharmacies market is segmented into oral medications, topical medications, suppositories, and others. The oral medications segment held the largest share of the market in 2019. The growth of this segment can be attributed to increasing compliance and rising number of prescriptions. Oral medications come in different forms, including solid tablets, capsules, chewable tablets, or lozenges that are to be swallowed whole or sucked. They are also available as drinkable liquids, including syrups, drops, or solutions. The topical medications segment is estimated to register the highest CAGR during the forecast period, owing to increase in supply of and demand for topical compounded preparations and regular practice of clinical use of compounded topical pain creams.

The US compounding pharmacy market is expected to grow owing to the drug shortage crisis in the US and benefits associated with compounded medications. On the other hand, product recalls and stringent regulatory requirements are likely to hinder the market growth during the forecast period.

Fagron; Triangle compounding pharmacy; Institutional pharmacy solutions, llc.; B. Braun melsungen ag; Pharmedium services llc.; Fresenius kabi ag; Avella specialty pharmacy; Pencol Compounding Pharmacy: Vertisis custom pharmacy; and US Compounding Inc. are among the leading companies operating in the US compounding pharmacy market.  

The report segments the US compounding pharmacies market as follows:

• Oral Medications
• Topical Medications
• Suppositories
• Others

• Pain Medications
• Dermatological Applications
• Hormone Replacement Therapies
• Others